PIRTOLI, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 9.474
EU - Europa 8.108
AS - Asia 4.549
SA - Sud America 726
AF - Africa 230
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 9
Totale 23.120
Nazione #
US - Stati Uniti d'America 9.318
GB - Regno Unito 2.057
RU - Federazione Russa 1.601
CN - Cina 1.591
SG - Singapore 1.381
IE - Irlanda 1.027
IT - Italia 723
UA - Ucraina 642
BR - Brasile 617
SE - Svezia 560
DE - Germania 494
VN - Vietnam 432
FR - Francia 424
HK - Hong Kong 373
FI - Finlandia 247
KR - Corea 207
IN - India 149
ZA - Sudafrica 122
ES - Italia 97
CA - Canada 85
TR - Turchia 77
BD - Bangladesh 62
NL - Olanda 47
JP - Giappone 43
IQ - Iraq 42
MX - Messico 41
PL - Polonia 36
NG - Nigeria 33
AR - Argentina 31
BE - Belgio 29
ID - Indonesia 25
AU - Australia 23
PK - Pakistan 22
IR - Iran 20
SA - Arabia Saudita 20
UZ - Uzbekistan 20
AT - Austria 19
LT - Lituania 18
EC - Ecuador 17
MY - Malesia 16
VE - Venezuela 16
IM - Isola di Man 14
KE - Kenya 14
MA - Marocco 13
CO - Colombia 11
DK - Danimarca 11
TN - Tunisia 11
CL - Cile 9
PH - Filippine 9
CI - Costa d'Avorio 8
CZ - Repubblica Ceca 8
DZ - Algeria 8
NP - Nepal 8
ET - Etiopia 7
EU - Europa 7
PE - Perù 7
RO - Romania 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
EG - Egitto 6
JM - Giamaica 6
JO - Giordania 6
PY - Paraguay 6
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
GR - Grecia 5
HU - Ungheria 5
RS - Serbia 5
KZ - Kazakistan 4
NO - Norvegia 4
OM - Oman 4
PA - Panama 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BB - Barbados 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
HN - Honduras 3
HR - Croazia 3
IL - Israele 3
PS - Palestinian Territory 3
BH - Bahrain 2
BW - Botswana 2
CR - Costa Rica 2
CY - Cipro 2
GA - Gabon 2
LK - Sri Lanka 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
Totale 23.103
Città #
Southend 1.774
Dublin 1.007
Dallas 953
Singapore 847
Fairfield 841
Ashburn 690
Chandler 617
Jacksonville 488
Santa Clara 478
Moscow 441
San Jose 413
Woodbridge 403
Beijing 396
Wilmington 372
Hong Kong 358
Seattle 308
Houston 306
Ann Arbor 300
Hefei 265
Cambridge 250
Seoul 203
Princeton 197
Siena 194
New York 193
Nanjing 173
The Dalles 151
Menlo Park 144
Ho Chi Minh City 132
Helsinki 122
Los Angeles 118
Johannesburg 112
Fremont 108
Lauterbourg 97
San Mateo 94
Hanoi 92
Council Bluffs 89
Munich 86
Dearborn 76
Málaga 70
Boardman 68
Buffalo 56
Milan 56
Shanghai 55
Shenyang 51
São Paulo 49
Florence 47
Izmir 47
Nanchang 47
San Diego 45
Rome 43
London 42
Orem 41
Dong Ket 37
Tianjin 37
Abuja 31
Kunming 30
Brussels 29
Columbus 29
Toronto 29
Warsaw 29
Lancaster 27
Montreal 27
Tokyo 27
Rio de Janeiro 25
Turku 25
Hebei 24
Changsha 23
Jinan 23
Redondo Beach 23
Chennai 22
Phoenix 22
Zhengzhou 22
Bengaluru 21
Denver 21
Atlanta 20
Da Nang 20
San Francisco 20
Falkenstein 19
Haiphong 19
Frankfurt am Main 18
Guangzhou 18
Jiaxing 18
Nuremberg 18
Amsterdam 17
Mumbai 17
Venezia 17
Brooklyn 16
Hangzhou 16
Redwood City 16
Stockholm 16
Tashkent 16
Chicago 14
Douglas 14
Bari 13
Belo Horizonte 13
Düsseldorf 13
Falls Church 13
Ningbo 13
Baghdad 12
Barnet 12
Totale 15.606
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 396
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 369
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients 341
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 335
Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma 326
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 322
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 321
microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to Temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells 311
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 302
Trehalose inhibits cell proliferation and amplifies long-term temozolomide- and radiation-induced cytotoxicity in melanoma cells: A role for autophagy and premature senescence 302
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 297
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 286
Diffusion-weighted magnetic resonance diagnosis of local recurrences of prostate cancer after radical prostatectomy: preliminary evaluation on twenty-seven cases 283
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 280
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 276
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 272
Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells 271
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 266
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 258
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 256
Beta-catenin and Gli1 are prognostic markers in glioblastoma 249
Detection of telomerase activity and correlation with mitotic and apoptotic indices, Ki-67 and expression of cyclins D1 and A in cutaneous melanoma 245
PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach 237
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk. 236
Silencing of cellular prion protein (PrPC) expression by DNA-antisense oligonucleotides induces autophagy-dependent cell death in glioma cells 232
AUTOCOUNTER, an ImageJ JavaScript to analyze LC3B-GFP expression dynamics in autophagy-induced astrocytoma cells 230
Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and Temozolomide combined treatments 230
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology). 229
Autofagia nei gliomi HG: analisi ed interpretazione di dati clinici e biologici 224
Lymphoepithelioma-like carcinoma of the endometrium 223
Associazione Epirubicina e Vincristina (Ev) nel trattamento del carcinoma mammario metastatico. Risultati preliminari 222
Beta-Catenin and Gli-1 as prognostic markers in Glioblastoma Multiforme. 221
Diffusion-weighted MR volumetry for assessing the response of rectal cancer to combined radiation therapy with chemotherapy 218
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 217
Emerging roles of microRNA in modulating cell-death processes in malignant glioma 216
Carcinoma with eccrine differentiation arising in a seborrhoeic keratosis. 215
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 214
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 213
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 212
Restaging patients with N2 non-small cell lung cancer after neoadjuvant therapy: TCMS accuracy using a multi-criteria approach 211
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 208
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 207
MR Volumetry of Rectal Cancer: DWI versus T2-weighted data sets. 206
Chirurgia conservativa e radioterapia a dosi "moderate" nel carcinoma mammario in fase iniziale 204
Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status 203
Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines 201
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 200
The prognostic role of Beclin 1 protein expression in high-grade gliomas 194
Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes 194
Combining Ipilimumab and Bevacizumab in Glioblastoma is Really Safe and Effective? 191
In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, Mib1, and topoisomerase IIα protein expression. 187
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? 187
Three-dimensional conformal radiotherapy, temozolomide chemotherapy and high-dose fractionated stereotactic boost in a protocol driven, post-operative treatment schedule for high-grade gliomas. 186
Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology) 186
Assessment of response to chemoradiation therapy in rectal cancer using MR volumetry based on diffusion-weighted data sets: a preliminary report [La volumetria con risonanza magnetica pesata in diffusione nella valutazione della risposta alla chemio-radioterapia nel tumore del retto: studio preliminare] 183
Adjuvant radiotherapy after radical prostatectomy: multinstitutional experience 181
Spindle cell lipoma of the orbit: a case report of an unusual orbital pathology 181
Surrenalectomia medica con aminoglutetimide nel carcinoma mammario in fase avanzata 181
Basi scientifiche per la definizione di linee-guida in ambito clinico per i tumori della tiroide dell’epitelio follicolare. 181
Beta-catenin and Gli1 are important prognostic factors in glioblastoma: combination with p53, EGFR and Mib1 markers to predict long term survival (paper #1628) 178
Benign lymphoepithelial lesion associated with squamous cell carcinoma of the skin: an immunohistochemical and molecular genetic study 178
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO). 177
Impact of timing of radiotherapy after conservative breast surgery on local control and metastases in pTis-T1-T2 N0 patients.Tuscany and Umbria Radiotherapy Departments experience. 176
Neoplasie di encefalo, occhio-orbita, ipofisi e midollo spinale 172
Neoplasie della sfera Otorinolaringoiatrica 169
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 166
Risultati terapeutici nel carcinoma mammario sottoposto a trattamento conservative basato sulla radioterapia. Lo standard di cura nel sud-est della Toscana negli anni 1996-2000 165
High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer 165
Tumori tiroidei 162
Cyclin D1 Co-localizes with Beclin-1 in Glioblastoma Recurrences: A Clue to a Therapy-induced, Autophagy-mediated Degradative Mechanism? 162
NEOPLASIE CEREBRALI, LINEE GUIDA AIOM. 160
Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology 159
CDK4, CDK6/cyclin‐d1 complex inhibition and radiotherapy for cancer control: a role for autophagy 159
Lymphatic vascularization in prostate adenocarcinoma: Correlation with tumor grade, androgen withdrawal and prognosis 156
Primary neuroendocrine (Merkel cell) carcinoma of the eyelid in a young woman - Report of a Case 154
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 153
Unresectable retroperitoneal malignant fibrous histiocytoma: Prolonged complete remission following chemoradiotherapy 153
The role of Radiation Oncologist in the management of antineoplastic drugs in Italy 150
Autophagy in Human Brain Cancer 150
Epidermal Growth Factor Receptor Expression May Correlate with Survival Through Clinical and Radiological Features of Aggressiveness in Glioblastoma Treated with Radiochemotherapy 148
Aromatase Inhibitors—Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects 147
Cytoplasmatic expression of the Beclin 1 autophagy protein gene product in a sereis of malignant glioma patients undergoing radio- and chemotherapy: a preliminary report. 144
Three-dimensional conformal radiotherapy, temozolomide chemotherapy, and high-dose fractionated boost in a protocol-driven, postoperative treatment schedule for high-grade gliomas 142
La radioterapia oncologica 139
null 139
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab 138
Updating the role of radiotherapy in the management of epithelial ovarian cancer 135
Prophylactic whole brain irradiation after complete response to primary treatment in limited stage small cell lung cancer: the experience of four radiotherapy units in Tuscany. 135
Oncology and a time of crisis. Science, complexity, ethic values, and incertitude. An argumentative essay 133
In Regard to Kubicek et al. 133
Restaging brain computerized tomography after treatment of non-operable lung neoplasms [La Tomografia Computerizzata dell'encefalo nella ristadiazione dopo terapia delle neoplasie polmonari non suscettibili di trattamento chirurgico] 133
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 132
Radiotherapy of malignant gliomas: results from conventional treatment methods and the prospects of advanced techniques [La radioterapia dei gliomi maligni. I risultati delle modalità tradizionali di trattamento e le prospettive delle tecniche avanzate] 130
null 130
Polichemioterapia precauzionale con cmf classico nel carcinoma della mammella con linfonodi ascellari positivi 129
The Istituto Toscano Tumori (ITT) and the radiotherapy Centers. 126
null 126
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in twelve italian radiation oncology centers 126
Conservative surgery and radiotherapy for ductal carcinoma of the breast. A retrospective analysis of 141 patients 124
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 123
Totale 20.301
Categoria #
all - tutte 66.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.272


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021184 0 0 0 0 0 0 0 0 0 0 0 184
2021/20221.355 100 149 132 97 69 54 58 73 70 141 118 294
2022/20232.066 114 162 291 292 200 401 34 177 197 86 65 47
2023/20241.679 59 38 139 85 61 451 622 59 9 52 22 82
2024/20253.043 92 146 290 164 396 210 48 180 180 128 362 847
2025/20267.428 631 1.049 757 915 1.694 318 834 208 258 490 151 123
Totale 23.393